APPG for Eye Health and Visual Impairment Inquiry Launch at Parliament
The College has been working with the All Party Parliamentary Group (APPG) for Eye Health and Visual Impairment and their inquiry which identifies solutions to the capacity crisis in England, to ensure that services meet demand. The inquiry report will be launched at a reception in Parliament on 6 June 2018 from 4pm to 6pm
SeeAbility launch new research report ‘Children in focus – a clear call to action’
SeeAbility has released new research, ‘Children in focus – a clear call to action’, that suggests thousands of children with learning disabilities in England’s special schools are missing out on vital eye tests and eye care despite being 28 times more likely to have a serious sight problem than other children. Around 100,000 children attend special schools in England,
Are patients with poorer vision more polite? A study examining door closing tendencies in patients with poor vision – (Are patients with poorer vision more polite? A study examining door closing tendencies in patients with poor vision, Published online: 2018-05-01; | doi:10.1038/s41433-018-0097-0)
Are patients with poorer vision more polite? A study examining door closing tendencies in patients with poor vision Are patients with poorer vision more polite? A study examining door closing tendencies in patients with poor vision, Published online: 01 May 2018; doi:10.1038/s41433-018-0097-0 Are patients with poorer vision more polite? A study examining door closing tendencies
Ophthalmic Safety Alert – Diabetic control and safe cataract surgery
The College has received queries from members to clarify whether there is a specific cut off for glycaemic control, either measured via HbA1C or a blood glucose level on the day, beyond which it is unsafe to proceed with cataract surgery. There is anecdotal evidence of cataract surgery cases being cancelled for surgery if their
Ophthalmic Safety Alert – intracameral cefuroxime
There are a range of cefuroxime preparations currently in use for the prevention of endophthalmitis in intraocular surgery. There are two licensed versions, Aprokam (Thea Pharmaceuticals) and Ximaract (from Bausch & Lomb), both available as a 50mg powder and diluent solution for injection. Also used are unlicensed prefilled syringes, of which some are compliant with